Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia

Cerebral Cortex

Volumn 23, Issue 9, 2013, Pages 2044-2057

  Voineskos, Aristotle N ^a,b,c   Felsky, Daniel ^a,b,c   Kovacevic, Natasa ^d   Tiwari, Arun K ^b,c   Zai, Clement ^b,c   Mallar Chakravarty, M ^a,c   Lobaugh, Nancy J ^a,c   Shenton, Martha E ^e   Rajji, Tarek K ^b,c   Miranda, Dielle ^b,c   Pollock, Bruce G ^b,c   Mulsant, Benoit H ^b,c   McIntosh, Anthony R ^d   Kennedy, James L ^b,c  

^a Research Imaging Centre   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ROTMAN RESEARCH INSTITUTE   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cognition; DTI; genetics; oligodendrocytes; white matter

Indexed keywords

ADULT; ARTICLE; BIOINFORMATICS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRACTOGRAPHY; WHITE MATTER;

COGNITION; DTI; GENETICS; OLIGODENDROCYTES; WHITE MATTER;

2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CEREBRAL CORTEX; COGNITION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE TISSUE PROTEINS; NEUREGULIN-1; OLIGODENDROGLIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84880327502     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs188     Document Type: Article

References (91)

1. Aberg K, Saetre P, Jareborg N, Jazin E. 2006. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci USA. 103:7482-7487.
2. Bartzokis G. 2002. Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology. 27:672-683.
3. Bartzokis G, Altshuler L. 2005. Reduced intracortical myelination in schizophrenia. Am J Psychiatry. 162:1229-1230.
4. Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J. 2003. Dysregulated brain development in adult men with schizophrenia: A magnetic resonance imaging study. Biol Psychiatry. 53:412-421.
5. Basser PJ, Pierpaoli C. 1996. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 111:209-219.
6. Beaulieu C. 2002. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 15:435-455.
7. Bokat CE, Goldberg TE. 2003. Letter and category fluency in schizophrenic patients: A meta-analysis. Schizophr Res. 64:73-78.
8. Budel S, Padukkavidana T, Liu BP, Feng Z, Hu F, Johnson S, Lauren J, Park JH, McGee AW, Liao J et al. 2008. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci. 28: 13161-13172.
9. Calhoun VD, Kiehl KA, Pearlson GD. 2008. Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks. Hum Brain Mapp. 29:828-838.
10. Camchong J, MacDonald AW, 3rd, Bell C, Mueller BA, Lim KO. 2011. Altered functional and anatomical connectivity in schizophrenia. Schizophr Bull. 37:640-650.
11. Catani M, Allin MP, Husain M, Pugliese L, Mesulam MM, Murray RM, Jones DK. 2007. Symmetries in human brain language pathways correlate with verbal recall. Proc Natl Acad Sci USA. 104:17163-17168.
12. Chen S, Velardez MO, Warot X, Yu ZX, Miller SJ, Cros D, Corfas G. 2006. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J Neurosci. 26:3079-3086.
13. Chiang MC, Barysheva M, Shattuck DW, Lee AD, Madsen SK, Avedissian C, Klunder AD, Toga AW, McMahon KL, de Zubicaray GI et al. 2009. Genetics of brain fiber architecture and intellectual performance. J Neurosci. 29:2212-2224.
14. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003. White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch Gen Psychiatry. 60:443-456.
15. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y et al. 2002. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 35:283-290.
16. Dwork AJ, Mancevski B, Rosoklija G. 2007. White matter and cognitive function in schizophrenia. Int J Neuropsychopharmacol. 10:513-536.
17. Ennis DB, Kindlmann G. 2006. Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med. 55:136-146.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York: Biometrics Research.
19. Fitzsimmons J, Kubicki M, Smith K, Bushell G, Estepar RS, Westin CF, Nestor PG, Niznikiewicz MA, Kikinis R, McCarley RW et al. 2009. Diffusion tractography of the fornix in schizophrenia. Schizophr Res. 107:39-46.
20. Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, Golembo S, Kanellopoulou I, Ng J, Hof PR et al. 2008. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry. 165:1024-1032.
21. Friston KJ, Frith CD. 1995. Schizophrenia: A disconnection syndrome? Clin Neurosci. 3:89-97.
22. Georgieva L, Dimitrova A, Ivanov D, Nikolov I, Williams NM, Grozeva D, Zaharieva I, Toncheva D, Owen MJ, Kirov G et al. 2008. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry. 64:419-427.
23. Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J et al. 2006. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci USA. 103:12469-12474.
24. Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC. 2007. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry. 164:813-819.
25. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 98:4746-4751.
26. Hamada M, Kiryu H, Sato K, Mituyama T, Asai K. 2009. Prediction of RNA secondary structure using generalized centroid estimators. Bioinformatics. 25:465-473.
27. Haroutunian V, Davis KL. 2007. Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia. Int J Neuropsychopharmacol. 10:499-502.
28. Heinrichs RW, Zakzanis KK. 1998. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology. 12:426-445.
29. Ioannidis JP. 2005. Why most published research findings are false. PLoS Med. 2:e124.
30. Jakovcevski I, Zecevic N. 2005. Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. J Neurosci. 25:10064-10073.
31. Jones DK. 2004. The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: A Monte Carlo study. Magn Reson Med. 51:807-815.
32. Jones DK, Williams SC, Gasston D, Horsfield MA, Simmons A, Howard R. 2002. Isotropic resolution diffusion tensor imaging with whole brain acquisition in a clinically acceptable time. Hum Brain Mapp. 15:216-230.
33. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:261-276.
34. Kochunov P, Glahn DC, Lancaster JL, Winkler AM, Smith S, Thompson PM, Almasy L, Duggirala R, Fox PT, Blangero J. 2010. Genetics of microstructure of cerebral white matter using diffusion tensor imaging. Neuroimage. 53:1109-1116.
35. Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N, Winterer G. 2009. ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology. 34:641-650.
36. Kubicki M, McCarley RW, Shenton ME. 2005. Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry. 18:121-134.
37. Kubicki M, McCarley R, Westin CF, Park HJ, Maier S, Kikinis R, Jolesz FA, Shenton ME. 2007. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 41:15-30.
38. Kubicki M, Styner M, Bouix S, Gerig G, Markant D, Smith K, Kikinis R, McCarley RW, Shenton ME. 2008. Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum. Schizophr Res. 106:125-131.
39. Law AJ, Kleinman JE, Weinberger DR, Weickert CS. 2007. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet. 16:129-141.
40. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR. 2006. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 50 SNPs associated with the disease. Proc Natl Acad Sci USA. 103:6747-6752.
41. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B, Peterson A, Roder J. 1994. Myelination in the absence of myelin-associated glycoprotein. Nature. 369:747-750.
42. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 15:1995-2002.
43. McCullumsmith RE, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis KL, Meador-Woodruff JH. 2007. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res. 90:15-27.
44. McIntosh AM, Maniega SM, Lymer GK, McKirdy J, Hall J, Sussmann JE, Bastin ME, Clayden JD, Johnstone EC, Lawrie SM. 2008. White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry. 64:1088-1092.
45. McIntosh AM, Moorhead TW, Job D, Lymer GK, Munoz Maniega S, McKirdy J, Sussmann JE, Baig BJ, Bastin ME, Porteous D et al. 2008. The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry. 13:1054-1059.
46. McIntosh AR, Bookstein FL, Haxby JV, Grady CL. 1996. Spatial pattern analysis of functional brain images using partial least squares. Neuroimage. 3:143-157.
47. McIntosh AR, Lobaugh NJ. 2004. Partial least squares analysis of neuroimaging data: Applications and advances. Neuroimage. 23 (Suppl 1):S250-263.
48. McTigue DM, Tripathi RB. 2008. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem. 107:1-19.
49. Meyer-Lindenberg A, Nicodemus KK, Egan MF, Callicott JH, Mattay V, Weinberger DR. 2008. False positives in imaging genetics. Neuroimage. 40:655-661.
50. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF, 3rd. 1992. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res. 41:237-248.
51. Miyata J, Yamada M, Namiki C, Hirao K, Saze T, Fujiwara H, Shimizu M, Kawada R, Fukuyama H, Sawamoto N et al. 2010. Reduced white matter integrity as a neural correlate of social cognition deficits in schizophrenia. Schizophr Res. 119:232-239.
52. Munafo MR, Thiselton DL, Clark TG, Flint J. 2006. Association of the NRG1 gene and schizophrenia: A meta-analysis. Mol Psychiatry. 11:539-546.
53. Nave KA, Salzer JL. 2006. Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol. 16:492-500.
54. Nestor PG, Kubicki M, Niznikiewicz M, Gurrera RJ, McCarley RW, Shenton ME. 2008. Neuropsychological disturbance in schizophrenia: A diffusion tensor imaging study. Neuropsychology. 22:246-254.
55. Nicolay DJ, Doucette JR, Nazarali AJ. 2007. Transcriptional control of oligodendrogenesis. Glia. 55:1287-1299.
56. O'Donnell LJ, Kubicki M, Shenton ME, Dreusicke MH, Grimson WE, Westin CF. 2006. A method for clustering white matter fiber tracts. Am J Neuroradiol. 27:1032-1036.
57. Oldfield RC. 1971. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia. 9:97-113.
58. Opiyo SO, Moriyama EN. 2009. Mining the Arabidopsis and rice genomes for cyclophilin protein families. Int J Bioinform Res Appl. 5:295-309.
59. Peirce TR, Bray NJ, Williams NM, Norton N, Moskvina V, Preece A, Haroutunian V, Buxbaum JD, Owen MJ, O'Donovan MC. 2006. Convergent evidence for 20,30-cyclic nucleotide 30-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry. 63:18-24.
60. Perez-Iglesias R, Tordesillas-Gutierrez D, McGuire PK, Barker GJ, Roiz-Santianez R, Mata I, de Lucas EM, Rodriguez-Sanchez JM, Ayesa-Arriola R, Vazquez-Barquero JL et al. 2010. White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry. 167:451-458.
61. Pernet V, Joly S, Christ F, Dimou L, Schwab ME. 2008. Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci. 28:7435-7444.
62. Pomarol-Clotet E, Canales-Rodriguez EJ, Salvador R, Sarro S, Gomar JJ, Vila F, Ortiz-Gil J, Iturria-Medina Y, Capdevila A, McKenna PJ. 2010. Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging. Mol Psychiatry. 15:823-830.
63. Raadsma HW, Moser G, Crump RE, Khatkar MS, Zenger KR, Cavanagh JA, Hawken RJ, Hobbs M, Barris W, Solkner J et al. 2008. Predicting genetic merit for mastitis and fertility in dairy cattle using genome wide selection and high density SNP screens. Dev Biol (Basel). 132:219-223.
64. Rajji TK, Ismail Z, Mulsant BH. 2009. Age at onset and cognition in schizophrenia: Meta-analysis. Br J Psychiatry. 195:286-293.
65. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, Chen C, Moore H, O'Donnell P et al. 2007. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci USA. 104:8131-8136.
66. Salter MG, Fern R. 2005. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature. 438: 1167-1171.
67. Schachner M, Bartsch U. 2000. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia. 29:154-165.
68. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. 2009. Training induces changes in white-matter architecture. Nat Neurosci. 12:1370-1371.
69. Segal D, Koschnick JR, Slegers LH, Hof PR. 2007. Oligodendrocyte pathophysiology: A new view of schizophrenia. Int J Neuropsychopharmacol. 10:503-511.
70. Shergill SS, Kanaan RA, Chitnis XA, O'Daly O, Jones DK, Frangou S, Williams SC, Howard RJ, Barker GJ, Murray RM et al. 2007. A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry. 164:467-473.
71. Snitz BE, Macdonald AW, 3rd, Carter CS. 2006. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: A meta-analytic review of putative endophenotypes. Schizophr Bull. 32:179-194.
72. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71:877-892.
73. Sullivan EV, Rohlfing T, Pfefferbaum A. 2008. Quantitative fiber tracking of lateral and interhemispheric white matter systems in normal aging: Relations to timed performance. Neurobiol Aging. 31:464-481.
74. Sullivan PF. 2007. Spurious genetic associations. Biol Psychiatry. 61:1121-1126.
75. Szeszko PR, Ardekani BA, Ashtari M, Kumra S, Robinson DG, Sevy S, Gunduz-Bruce H, Malhotra AK, Kane JM, Bilder RM et al. 2005. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: A diffusion tensor imaging study. Am J Psychiatry. 162:602-605.
76. Szeszko PR, Robinson DG, Ashtari M, Vogel J, Betensky J, Sevy S, Ardekani BA, Lencz T, Malhotra AK, McCormack J et al. 2008. Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology. 33:976-984.
77. Tan HY, Sust S, Buckholtz JW, Mattay VS, Meyer-Lindenberg A, Egan MF, Weinberger DR, Callicott JH. 2006. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. Am J Psychiatry. 163:1969-1977.
78. Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, Falls DL, Einheber S, Salzer JL. 2008. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia. 56:284-293.
79. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362:798-805.
80. Tura E, Turner JA, Fallon JH, Kennedy JL, Potkin SG. 2008. Multivariate analyses suggest genetic impacts on neurocircuitry in schizophrenia. Neuroreport. 19:603-607.
81. Ursu S, Kring AM, Gard MG, Minzenberg MJ, Yoon JH, Ragland JD, Solomon M, Carter CS. 2011. Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. Am J Psychiatry. 168:276-285.
82. Voineskos A, Lang D, Zai G, Bulgin N, Shaikh S, Su W, Kopala L, MacEwan G, Thornton A, Smith J et al. 2008. MAG gene variation and cortical gray matter volume in first episode schizophrenia. Brain Imaging Behav. 2:117-122.
83. Voineskos AN. 2009. Converging evidence for the Nogo-66 receptor gene in schizophrenia. J Neurosci. 29:5045-5047.
84. Voineskos AN, de Luca V, Bulgin NL, van Adrichem Q, Shaikh S, Lang DJ, Honer WG, Kennedy JL. 2008. A family-based association study of the myelin-associated glycoprotein and 20,30-cyclic nucleotide 30-phosphodiesterase genes with schizophrenia. Psychiatr Genet. 18:143-146.
85. Voineskos AN, Lobaugh NJ, Bouix S, Rajji TK, Miranda D, Kennedy JL, Mulsant BH, Pollock BG, Shenton ME. 2010. Diffusion tensor tractography findings in schizophrenia across the adult lifespan. Brain. 133:1494-1504.
86. Voineskos AN, O'Donnell LJ, Lobaugh NJ, Markant D, Ameis SH, Niethammer M, Mulsant BH, Pollock BG, Kennedy JL, Westin CF et al. 2009. Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography. Neuroimage. 45:370-376.
87. Voineskos AN, Rajji TK, Lobaugh NJ, Miranda D, Shenton ME, Kennedy JL, Pollock BG, Mulsant BH. 2012. Age-related decline in white matter tract integrity and cognitive performance: A DTI tractography and structural equation modeling study. Neurobiol Aging. 33:21-34.
88. Wang F, Jiang T, Sun Z, Teng SL, Luo X, Zhu Z, Zang Y, Zhang H, Yue W, Qu M et al. 2009. Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. J Psychiatry Neurosci. 34:181-186.
89. Whitford TJ, Kubicki M, Schneiderman JS, O'Donnell LJ, King R, Alvarado JL, Khan U, Markant D, Nestor PG, Niznikiewicz M et al. 2010. Corpus callosum abnormalities and their association with psychotic symptoms in patients with schizophrenia. Biol Psychiatry. 68:70-77.
90. Winterer G, Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N. 2008. Association of 50 end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. Neuroimage. 40:712-718.
91. Zhang Y, Xu H, Jiang W, Xiao L, Yan B, He J, Wang Y, Bi X, Li X, Kong J et al. 2008. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse. Schizophr Res. 106:182-191.